Hepcidin regulation in the anemia of inflammation

Current Opinion in Hematology

Volumn 23, Issue 3, 2016, Pages 189-197

  Wang, Chia Yu ^a   Babitt, Jodie L ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Anemia; Ferroportin; Hepcidin; Inflammation; Iron

Indexed keywords

6 [4 (1 PIPERAZINYL)PHENYL] 3 (4 QUINOLINYL)PYRAZOLO[1,5 A]PYRIMIDINE; BONE MORPHOGENETIC PROTEIN 6; FERROPORTIN; FOLLISTATIN; GROWTH FACTOR; HEMOJUVELIN; HEPARIN; HEPCIDIN; HYDROGEN SULFIDE; INTERLEUKIN 6; MYELOPID; NOX H 94; PEPTIDE HORMONE ANTAGONIST; SILTUXIMAB; SMAD PROTEIN; SMAD1 PROTEIN; SMAD5 PROTEIN; SMAD8 PROTEIN; STAT3 PROTEIN; TOCILIZUMAB; UNCLASSIFIED DRUG;

ANEMIA; ANEMIA OF INFLAMMATION; ENDOPLASMIC RETICULUM STRESS; HORMONAL REGULATION; HUMAN; INFLAMMATION; IRON BALANCE; NONHUMAN; PHASE 1 CLINICAL TRIAL (TOPIC); PHASE 2 CLINICAL TRIAL (TOPIC); PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; REVIEW; METABOLISM;

ANEMIA; HEPCIDINS; HUMANS; INFLAMMATION;

EID: 84958780878     PISSN: 10656251     EISSN: 15317048     Source Type: Journal    
DOI: 10.1097/MOH.0000000000000236     Document Type: Review

References (63)

1. Weiss G. Anemia of chronic disorders: new diagnostic tools and new treatment strategies. Semin Hematol 2015; 52:313-320.
2. Nemeth E, Ganz T. Anemia of inflammation. Hematol Oncol Clin North Am 2014; 28:671-681.
3. McCranor BJ, Langdon JM, Prince OD, et al. Investigation of the role of interleukin-6 and hepcidin antimicrobial peptide in the development of anemia with age. Haematologica 2013; 98:1633-1640.
4. Ganz T. Systemic iron homeostasis. Physiol Rev 2013; 93:1721-1741.
5. Drakesmith H, Nemeth E, Ganz T. Ironing out Ferroportin. Cell Metab 2015; 22:777-787.
6. Taniguchi R, Kato HE, Font J, et al. Outward- and inward-facing structures of a putative bacterial transition-metal transporter with homology to ferroportin. Nat Commun 2015; 6:8545.
7. Ganz T, Nemeth E. Iron homeostasis in host defence and inflammation. Nat Rev Immunol 2015; 15:500-510.
8. Core AB, Canali S, Babitt JL. Hemojuvelin and bone morphogenetic protein (BMP) signaling in iron homeostasis. Front Pharmacol 2014; 5:104.
9. Healey EG, Bishop B, Elegheert J, et al. Repulsive guidance molecule is a structural bridge between neogenin and bone morphogenetic protein. Nat Struct Mol Biol 2015; 22:458-465.
10. Wu XG, Wang Y, Wu Q, et al. HFE interacts with the BMP type I receptor ALK3 to regulate hepcidin expression. Blood 2014; 124:1335-1543.
11. Latour C, Besson-Fournier C, Meynard D, et al. Differing impact of the deletion of hemochromatosis-associated molecules HFE and transferrin receptor-2 on the iron phenotype of mice lacking bone morphogenetic protein 6 or hemojuvelin. Hepatology 2016; 63:126-137.
12. Rodriguez R, Jung CL, Gabayan V, et al. Hepcidin induction by pathogens and pathogen-derived molecules is strongly dependent on interleukin-6. Infect Immun 2014; 82:745-752.
13. Wallace DF, Subramaniam VN. Analysis of IL-22 contribution to hepcidin induction and hypoferremia during the response to LPS in vivo. Int Immunol 2015; 27:281-287.
14. Lee P, Peng H, Gelbart T, et al. Regulation of hepcidin transcription by interleukin-1 and interleukin-6. Proc Natl Acad Sci U S A 2005; 102:1906-1910.
15. Kramer F, Torzewski J, Kamenz J, et al. Interleukin-1beta stimulates acute phase response and C-reactive protein synthesis by inducing an NFkappaBand C/EBPbeta-dependent autocrine interleukin-6 loop. Mol Immunol 2008; 45:2678-2689.
16. Shanmugam NK, Chen K, Cherayil BJ. Commensal bacteria-induced interleukin 1β (IL-1β) secreted by macrophages up-regulates hepcidin expression in hepatocytes by activating the bone morphogenetic protein signaling pathway. J Biol Chem 2015; 290:30637-30647.
17. Casanovas G, Banerji A, d'Alessio F, et al. A multiscale model of hepcidin promoter regulation reveals factors controlling systemic iron homeostasis. PLoS Comput Biol 2014; 10:e1003421.
18. Besson-Fournier C, Latour C, Kautz L, et al. Induction of activin B by inflammatory stimuli up-regulates expression of the iron-regulatory peptide hepcidin through SMAD1/5/8 signaling. Blood 2012; 120:431-439.
19. Canali S, Core AB, Zumbrennen-Bullough KB, et al. Activin B induces noncanonical SMAD1/5/8 signaling via BMP type I receptors in hepatocytes: evidence for a role in hepcidin induction by inflammation in male mice. Endocrinology 2016. [Epub ahead of print]
20. Pietrangelo A. Genetics, genetic testing, and management of hemochromatosis: 15 years since hepcidin. Gastroenterology 2015; 149:1240-1251.
21. Vecchi C, Montosi G, Garuti C, et al. Gluconeogenic signals regulate iron homeostasis via hepcidin in mice. Gastroenterology 2014; 146:1060-1069.
22. Latour C, Kautz L, Besson-Fournier C, et al. Testosterone perturbs systemic iron balance through activation of epidermal growth factor receptor signaling in the liver and repression of hepcidin. Hepatology 2014; 59:683-694.
23. Li X, Rhee DK, Malhotra R, et al. Progesterone receptor membrane component-1 regulates hepcidin biosynthesis. J Clin Invest 2016; 126:389-401.
24. Sonnweber T, Nachbaur D, Schroll A, et al. Hypoxia induced downregulation of hepcidin is mediated by platelet derived growth factor BB. Gut 2014; 63:1951-1959.
25. Mleczko-Sanecka K, Roche F, da Silva AR, et al. Unbiased RNAi screen for hepcidin regulators links hepcidin suppression to proliferative Ras/RAF and nutrient-dependent mTOR signaling. Blood 2014; 123:1574-1585.
26. Kautz L, Jung G, Valore EV, et al. Identification of erythroferrone as an erythroid regulator of iron metabolism. Nat Genet 2014; 46:678-684.
27. Kautz L, Jung G, Nemeth E, Ganz T. Erythroferrone contributes to recovery from anemia of inflammation. Blood 2014; 124:2569-2574.
28. Kautz L, Jung G, Du X, et al. Erythroferrone contributes to hepcidin suppression and iron overload in a mouse model of β-thalassemia. Blood 2015; 126:2031-2037.
29. Gardenghi S, Renaud TM, Meloni A, et al. Distinct roles for hepcidin and interleukin-6 in the recovery from anemia in mice injected with heat-killed Brucella abortus. Blood 2014; 123:1137-1145.
30. Kim A, Fung E, Parikh SG, et al. A mouse model of anemia of inflammation: complex pathogenesis with partial dependence on hepcidin. Blood 2014; 123:1129-1136.
31. Langdon JM, Yates SC, Femnou LK, et al. Hepcidin-dependent and hepcidinindependent regulation of erythropoiesis in a mouse model of anemia of chronic inflammation. Am J Hematol 2014; 89:470-479.
32. McCranor BJ, Kim MJ, Cruz NM, et al. Interleukin-6 directly impairs the erythroid development of human TF-1 erythroleukemic cells. Blood Cells Mol Dis 2014; 52:126-133.
33. Macciò A, Madeddu C, Gramignano G, et al. The role of inflammation, iron, and nutritional status in cancer-related anemia: results of a large, prospective, observational study. Haematologica 2015; 100:124-132.
34. Kim A, Rivera S, Shprung D, et al. Mouse models of anemia of cancer. PLoS One 2014; 9:e93283.
35. Barber MF, Elde NC. Nutritional immunity. Escape from bacterial iron piracy through rapid evolution of transferrin. Science 2014; 346:1362-1366.
36. Armitage AE, Stacey AR, Giannoulatou E, et al. Distinct patterns of hepcidin and iron regulation during HIV-1, HBV, and HCV infections. Proc Natl Acad Sci U S A 2014; 111:12187-12192.
37. Arezes J, Jung G, Gabayan V, et al. Hepcidin-induced hypoferremia is a critical host defense mechanism against the siderophilic bacterium Vibrio vulnificus. Cell Host Microbe 2015; 17:47-57.
38. Darton TC, Blohmke CJ, Giannoulatou E, et al. Rapidly escalating hepcidin and associated serum iron starvation are features of the acute response to typhoid infection in humans. PLoS Negl Trop Dis 2015; 9:e0004029.
39. Kim DK, Jeong JH, Lee JM, et al. Inverse agonist of estrogen-related receptor γ controls Salmonella typhimurium infection by modulating host iron homeostasis. Nat Med 2014; 20:419-424.
40. Nairz M, Haschka D, Demetz E, Weiss G. Iron at the interface of immunity and infection. Front Pharmacol 2014; 5:152.
41. Brown DE, Nick HJ, McCoy MW, et al. Increased ferroportin-1 expression and rapid splenic iron loss occur with anemia caused by Salmonella enterica Serovar Typhimurium infection in mice. Infect Immun 2015; 83:2290-2299.
42. Guida C, Altamura S, Klein FA, et al. A novel inflammatory pathway mediating rapid hepcidin-independent hypoferremia. Blood 2015; 125:2265-2275.
43. Deschemin JC, Vaulont S. Role of hepcidin in the setting of hypoferremia during acute inflammation. PLoS One 2013; 8:e61050.
44. Zumbrennen-Bullough K, Babitt JL. The iron cycle in chronic kidney disease (CKD): from genetics and experimental models to CKD patients. Nephrol Dial Transplant 2014; 29:263-273.
45. Sazawal S, Black RE, Ramsan M, et al. Effects of routine prophylactic supplementation with iron and folic acid on admission to hospital and mortality in preschool children in a high malaria transmission setting: community-based, randomised, placebo-controlled trial. Lancet 2006; 367:133-143.
46. Pasricha SR, Atkinson SH, Armitage AE, et al. Expression of the iron hormone hepcidin distinguishes different types of anemia in African children. Sci Transl Med 2014; 6:235re3.
47. Atkinson SH, Armitage AE, Khandwala S, et al. Combinatorial effects of malaria season, iron deficiency, and inflammation determine plasma hepcidin concentration in African children. Blood 2014; 123:3221-3229.
48. van Santen S, de Mast Q, Oosting JD, et al. Hematologic parameters predicting a response to oral iron therapy in chronic inflammation. Haematologica 2014; 99:e171-e173.
49. Theurl M, Nairz M, Schroll A, et al. Hepcidin as a predictive factor and therapeutic target in erythropoiesis-stimulating agent treatment for anemia of chronic disease in rats. Haematologica 2014; 99:1516-1524.
50. Song SN, Iwahashi M, Tomosugi N, et al. Comparative evaluation of the effects of treatment with tocilizumab and TNF-α inhibitors on serum hepcidin, anemia response and disease activity in rheumatoid arthritis patients. Arthritis Res Ther 2013; 15:R141.
51. Isaacs JD, Harari O, Kobold U, et al. Effect of tocilizumab on haematological markers implicates interleukin-6 signalling in the anaemia of rheumatoid arthritis. Arthritis Res Ther 2013; 15:R204.
52. Casper C, Chaturvedi S, Munshi N, et al. Analysis of inflammatory and anemiarelated biomarkers in a randomized, double-blind, placebo-controlled study of siltuximab (anti-IL-6 monoclonal antibody) in patients with multicentric castleman disease. Clin Cancer Res 2015; 21:4294-4304.
53. Xin H, Wang M, Tang W, et al. Hydrogen sulfide attenuates inflammatory hepcidin by reducing IL-6 secretion and promoting SIRT1-mediated STAT3 deacetylation. Antioxid Redox Signal 2015; 24:70-83.
54. Mayeur C, Kolodziej SA, Wang A, et al. Oral administration of a bone morphogenetic protein type I receptor inhibitor prevents the development of anemia of inflammation. Haematologica 2015; 100:e68-e71.
55. Theurl I, Schroll A, Sonnweber T, et al. Pharmacologic inhibition of hepcidin expression reverses anemia of chronic inflammation in rats. Blood 2011; 118:4977-4984.
56. Sun CC, Vaja V, Chen S, et al. A hepcidin lowering agent mobilizes iron for incorporation into red blood cells in an adenine-induced kidney disease model of anemia in rats. Nephrol Dial Transplant 2013; 28:1733-1743.
57. Poli M, Asperti M, Naggi A, et al. Glycol-split nonanticoagulant heparins are inhibitors of hepcidin expression in vitro and in vivo. Blood 2014; 123:1564-1573.
58. Poli M, Asperti M, Ruzzenenti P, et al. Oversulfated heparins with low anticoagulant activity are strong and fast inhibitors of hepcidin expression in vitro and in vivo. Biochem Pharmacol 2014; 92:467-475.
59. Andriopoulos B Jr, Corradini E, Xia Y, et al. BMP6 is a key endogenous regulator of hepcidin expression and iron metabolism. Nat Genet 2009; 41:482-487.
60. Böser P, Seemann D, Liguori MJ, et al. Antirepulsive guidance molecule C (RGMc) antibodies increases serum iron in rats and cynomolgus monkeys by hepcidin downregulation. AAPS J 2015; 17:930-938.
61. Schwoebel F, van Eijk LT, Zboralski D, et al. The effects of the antihepcidin Spiegelmer NOX-H94 on inflammation-induced anemia in cynomolgus monkeys. Blood 2013; 121:2311-2315.
62. van Eijk LT, John AS, Schwoebel F, et al. Effect of the antihepcidin Spiegelmer lexaptepid on inflammation-induced decrease in serum iron in humans. Blood 2014; 124:2643-2646.
63. Cooke KS, Hinkle B, Salimi-Moosavi H, et al. A fully human antihepcidin antibody modulates iron metabolism in both mice and nonhuman primates. Blood 2013; 122:3054-3061.